A nonrandomized, single-arm confirmatory trial of expanded endoscopic submucosal dissection indication for undifferentiated early gastric cancer: Japan Clinical Oncology Group study (JCOG1009/1010).

Kohei TakizawaHiroyuki OnoNoriaki HasuikeAtsuo TakashimaKeiko MinashiNarikazu BokuRyoji KushimaHiroshi KatayamaGakuto OgawaHaruhiko FukudaJunko FujisakiIchiro OdaTomonori YanoShinichiro HoriHisashi DoyamaKingo HirasawaYoshinobu YamamotoRyu IshiharaSatoshi TanabeYasumasa NiwaMasahiro NakagawaMasanori TerashimaManabu Mutonull null

Published in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2020)

ESD can be a curative and less invasive treatment for UD-EGC for patients meeting the eligibility criteria of this study.

Keyphrases

endoscopic submucosal dissection
end stage renal disease
prognostic factors
newly diagnosed
ejection fraction
phase iii
chronic kidney disease
clinical trial
peritoneal dialysis
palliative care
study protocol
combination therapy
smoking cessation